Supernus Pharmaceuticals to Participate in September Investor Conferences

Supernus Pharmaceuticals to Participate in September Investor Conferences
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today management will participate in the following September investor conferences: